Company Valuation: Gilead Sciences, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 91,081 107,677 100,942 115,118 152,281 206,430 - -
Change - 18.22% -6.25% 14.04% 32.28% 35.56% - -
Enterprise Value (EV) 1 118,530 126,522 118,665 131,838 169,585 227,476 218,041 208,094
Change - 6.74% -6.21% 11.1% 28.63% 34.14% -4.15% -4.56%
P/E 14.7x 23.6x 18x 243x 18.1x -39.1x 20x 18.7x
PBR 4.32x 5.05x 4.48x 5.98x 6.73x 15.8x 10.8x 7.95x
PEG - -0.9x 0.8x -2.7x 0x 0x -0x 2.56x
Capitalization / Revenue 3.34x 3.95x 3.72x 4x 5.17x 6.58x 6.14x 5.92x
EV / Revenue 4.34x 4.64x 4.38x 4.59x 5.76x 7.25x 6.49x 5.97x
EV / EBITDA 8.12x 8.86x 9.01x 11.7x 10.6x 45.7x 11.8x 11.3x
EV / EBIT 9.45x 10.4x 11.3x 15.5x 12.9x 98x 13.2x 12x
EV / FCF 11x 15.2x 16x 12.8x 17.9x 58.1x 16.2x 15x
FCF Yield 9.12% 6.59% 6.25% 7.82% 5.58% 1.72% 6.19% 6.66%
Dividend per Share 2 2.84 2.92 3 3.08 3.16 3.297 3.376 3.094
Rate of return 3.91% 3.4% 3.7% 3.33% 2.57% 1.98% 2.03% 1.86%
EPS 2 4.93 3.64 4.5 0.38 6.78 -4.252 8.303 8.91
Distribution rate 57.6% 80.2% 66.7% 811% 46.6% -77.5% 40.7% 34.7%
Net sales 1 27,305 27,281 27,116 28,754 29,443 31,383 33,603 34,852
EBITDA 1 14,598 14,283 13,177 11,287 15,953 4,982 18,414 18,486
EBIT 1 12,548 12,180 10,484 8,520 13,193 2,321 16,473 17,328
Net income 1 6,225 4,592 5,665 480 8,510 -5,292 10,697 11,301
Net Debt 1 27,449 18,845 17,723 16,720 17,304 21,047 11,612 1,664
Reference price 2 72.61 85.85 81.01 92.37 122.74 166.43 166.43 166.43
Nbr of stocks (in thousands) 1,254,384 1,254,244 1,246,042 1,246,266 1,240,680 1,240,339 - -
Announcement Date 2/2/22 2/2/23 7/2/24 12/2/25 11/2/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-39.16x7.25x45.68x1.98% 206B
39.52x13.4x28.41x0.5% 1,200B
36.48x6.57x18.48x1.99% 651B
36.15x8.33x17.22x2.43% 506B
21.54x5.2x13.03x2.51% 377B
94.27x5.43x23.16x2.56% 330B
22.77x5.51x13.41x2.89% 288B
22.87x4.6x13.08x1.92% 272B
22.66x7.01x12.88x2.3% 236B
11.47x4.12x8.47x4.29% 171B
Average 26.86x 6.74x 19.38x 2.34% 424B
Weighted average by Cap. 33.20x 8.26x 20.94x 1.88%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Gilead Sciences, Inc.

Historical PBR trend

Valuation ratios - PBR - Gilead Sciences, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Gilead Sciences, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Gilead Sciences, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Gilead Sciences, Inc.
  1. Stock Market
  2. Stocks
  3. GILD Stock
  4. Valuation Gilead Sciences, Inc.